Acrivon Therapeutics (ACRV) Revenue & Revenue Breakdown
Acrivon Therapeutics Revenue Highlights
00
Acrivon Therapeutics Revenue by Period
Acrivon Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | - |
Acrivon Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.88M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | - |
Acrivon Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ADAG | Adagene | $18.11M | $833.34K |
ANAB | AnaptysBio | $17.16M | $30.02M |
MOLN | Molecular Partners | $7.04M | $2.74M |
OPT | Opthea | $108.41K | $61.27K |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
ANTX | AN2 Therapeutics | - | - |
AVTE | Aerovate Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |